Search hospitals > Illinois > Chicago
University of Illinois Cancer Center
Claim this profileChicago, Illinois 60612
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Lymphoma
Conducts research for Non-Small Cell Lung Cancer
118 reported clinical trials
16 medical researchers
Summary
University of Illinois Cancer Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Non-Small Cell Lung Cancer and other specialties. University of Illinois Cancer Center is involved with conducting 118 clinical trials across 151 conditions. There are 16 research doctors associated with this hospital, such as Lawrence E. Feldman, Shikha Jain, Paul Rubinstein, MD, and Oana Danciu.Area of expertise
1Lung Cancer
Global LeaderHER2 positive
Stage IV
Stage III
2Breast Cancer
Global LeaderStage IV
HER2 positive
Stage III
Top PIs
Lawrence E. FeldmanUniversity of Illinois6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
30 reported clinical trials
42 drugs studied
Shikha JainUniversity of Illinois6 years of reported clinical research
Studies Stomach Cancer
Studies Thyroid Cancer
15 reported clinical trials
31 drugs studied
Paul Rubinstein, MDUniversity of Illinois2 years of reported clinical research
Expert in Lymphoma
Studies B-Cell Lymphoma
14 reported clinical trials
35 drugs studied
Oana DanciuUniversity of Illinois9 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
12 reported clinical trials
47 drugs studied
Clinical Trials running at University of Illinois Cancer Center
Breast Cancer
Lung Cancer
Lymphoma
Thyroid Cancer
Ovarian Cancer
Multiple Myeloma
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Small Cell Lung Cancer
Relapse
Low Dose Azacitidine
for Early Stage Breast Cancer
This trial is testing if low dose azacitidine can help the immune system fight high-risk early stage breast cancer. The treatment aims to increase immune cells that attack cancer cells. It targets patients whose cancer is more likely to return or spread.
Recruiting1 award Phase 210 criteria
BL-M07D1
for HER2-Positive Cancer
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.
Recruiting1 award Phase 1
Alisertib + Endocrine Therapy
for Breast Cancer
PUMA-ALI-1201 is a randomized, dose optimization, multicenter, Phase 2 study of alisertib administered in combination with endocrine therapy in participants with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two prior lines of endocrine therapy in the recurrent or metastatic setting. This study is intended to evaluate the optimal alisertib dose administered in combination with the selected endocrine therapy. The study is also planned to evaluate the efficacy, safety, and pharmacokinetics of alisertib in combination with endocrine and to identify the biomarker-defined subgroup(s) that may benefit most from combined alisertib and endocrine therapy.
Recruiting1 award Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Illinois Cancer Center?
University of Illinois Cancer Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Non-Small Cell Lung Cancer and other specialties. University of Illinois Cancer Center is involved with conducting 118 clinical trials across 151 conditions. There are 16 research doctors associated with this hospital, such as Lawrence E. Feldman, Shikha Jain, Paul Rubinstein, MD, and Oana Danciu.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.